Zydus MedTech has formed a global licensing agreement with Braile Biomedica to market Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe, and other markets, aimed at expanding in the interventional cardiology sector. The TAVI market is valued at over USD 6 billion and is growing due to increased demand for minimally invasive cardiac procedures, with the partnership allowing Zydus to manufacture select components of the TAVI system.